Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic significance and mechanism of Treg infiltration in human brain tumors
Joannes F.M. Jacobs, Albert J. S. Idema, Kalijn F. Bol, et al.
Journal of Neuroimmunology (2010) Vol. 225, Iss. 1-2, pp. 195-199
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

The immune contexture in human tumours: impact on clinical outcome
Wolf H. Fridman, Franck Pagès, Catheriné Sautès-Fridman, et al.
Nature reviews. Cancer (2012) Vol. 12, Iss. 4, pp. 298-306
Closed Access | Times Cited: 4375
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1194
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
Ekaterina Friebel, Konstantina Kapolou, Susanne Unger, et al.
Cell (2020) Vol. 181, Iss. 7, pp. 1626-1642.e20
Open Access | Times Cited: 510
Immune microenvironment of gliomas
Anna Gieryng, Dominika Pszczolkowska, Kacper A. Walentynowicz, et al.
Laboratory Investigation (2017) Vol. 97, Iss. 5, pp. 498-518
Open Access | Times Cited: 456
Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
Orin Bloch, Courtney A. Crane, Rajwant Kaur, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 12, pp. 3165-3175
Open Access | Times Cited: 430
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E. Kim, Mira A. Patel, Antonella Mangraviti, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 1, pp. 124-136
Open Access | Times Cited: 396
Immune Microenvironment in Glioblastoma Subtypes
Zhihong Chen, Dolores Hambardzumyan
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 364
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik, Aurélie Poli, Nicolaas H. C. Brons, et al.
Journal of Neuroimmunology (2013) Vol. 264, Iss. 1-2, pp. 71-83
Open Access | Times Cited: 357
The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
Jacques Mbongue, Dequina Nicholas, Timothy Torrez, et al.
Vaccines (2015) Vol. 3, Iss. 3, pp. 703-729
Open Access | Times Cited: 313
Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β
Jennifer Lohr, Thomas Ratliff, Andrea Huppertz, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 13, pp. 4296-4308
Open Access | Times Cited: 309
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson, et al.
Immunological Reviews (2011) Vol. 241, Iss. 1, pp. 104-118
Open Access | Times Cited: 263
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
Abhishek D. Garg, Lien Vandenberk, Carolien Koks, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 328
Closed Access | Times Cited: 253
Immune Evasion Strategies of Glioblastoma
Seyed‐Mostafa Razavi, Karen E. Lee, Benjamin Jin, et al.
Frontiers in Surgery (2016) Vol. 3
Open Access | Times Cited: 237
miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
Jun Wei, Fei Wang, Ling-Yuan Kong, et al.
Cancer Research (2013) Vol. 73, Iss. 13, pp. 3913-3926
Open Access | Times Cited: 236
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
Syreeta DeCordova, Abhishek Shastri, Anthony G. Tsolaki, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 235
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Ana Rita Pombo Antunes, Isabelle Scheyltjens, Johnny Duerinck, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 228
Trial watch
Laura Senovilla, Erika Vacchelli, Jérôme Galon, et al.
OncoImmunology (2012) Vol. 1, Iss. 8, pp. 1323-1343
Open Access | Times Cited: 220
PD-1 marks dysfunctional regulatory T cells in malignant gliomas
Daniel E. Lowther, Brittany A. Goods, Liliana E. Lucca, et al.
JCI Insight (2016) Vol. 1, Iss. 5
Open Access | Times Cited: 217
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
Tyler J. Alban, Alvaro G. Alvarado, Mia Dahl Sørensen, et al.
JCI Insight (2018) Vol. 3, Iss. 21
Open Access | Times Cited: 171
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang, Aitian Li, Qingyang Lei, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 164
Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
Ziyi Bai, Yao Zhou, Zifan Ye, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 117
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma
Haofei Liu, Qiwen Zhao, Leyong Tan, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 693-710.e8
Open Access | Times Cited: 63
The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
Elizabeth A. Vasievich, Leaf Huang
Molecular Pharmaceutics (2011) Vol. 8, Iss. 3, pp. 635-641
Open Access | Times Cited: 191
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
Johannes vom Berg, Melissa Vrohlings, Sergio Haller, et al.
The Journal of Experimental Medicine (2013) Vol. 210, Iss. 13, pp. 2803-2811
Open Access | Times Cited: 188
Page 1 - Next Page

Scroll to top